SCHEMBL20201472

SCHEMBL20201472

Cc1cccc(N2CN(C)c3ncncc32)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.41
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
ALDH1A1 P00352 4/20 0.39
CYP3A4 P08684 3/20 0.39
CYP2C19 P33261 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 2/20 0.39
GAA P10253 1/20 0.36
TSHR P16473 2/20 0.36
RECQL P46063 1/20 0.36
ADRB1 P08588 1/20 0.35
LMNA P02545 2/20 0.34
OPRM1 P35372 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TP53 P04637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
FNTA P49354 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20201475 0.89 MAPT (0.41) MAPTMEN1KMT2AALDH1A1CYP3A4
SCHEMBL17754709 0.89 CYP1A2 (0.44) MEN1KMT2AALDH1A1CYP3A4CYP2C19
SCHEMBL20201466 0.81 GAA (0.49) MAPTKMT2ACYP3A4CYP2C19GAA
SCHEMBL17754705 0.77 CYP1A2 (0.44) MAPTMEN1KMT2AALDH1A1CYP3A4
SCHEMBL20201469 0.77 CYP3A4 (0.41) MAPTKMT2AALDH1A1CYP3A4CYP2C19
SCHEMBL20201474 0.77 CYP3A4 (0.41) MAPTKMT2AALDH1A1CYP3A4CYP2C19
SCHEMBL20201473 0.77 CYP3A4 (0.43) MAPTMEN1KMT2AALDH1A1CYP3A4
SCHEMBL20201468 0.74 CYP3A4 (0.44) MAPTMEN1KMT2AALDH1A1CYP3A4
SCHEMBL24845002 0.73 CYP1A2 (0.40) MAPTMEN1KMT2AALDH1A1CYP3A4
SCHEMBL20201470 0.72 GAA (0.46) MAPTKMT2AALDH1A1CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180151816-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180151816-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES TEC, EML4, TPR MAPT 230/4885MEN1 1189/4885KMT2A 1118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.